Delayed pain decrease following M1 tDCS in spinal cord injury: A randomized controlled clinical trial
Aurore Thibaut, Sandra Carvalho, Leslie R Morse, Ross Zafonte, Felipe Fregni, Aurore Thibaut, Sandra Carvalho, Leslie R Morse, Ross Zafonte, Felipe Fregni
Abstract
Despite some encouraging findings for the treatment of neuropathic pain in patients with spinal cord injury (SCI), transcranial direct current stimulation (tDCS) directed to the primary motor cortex (M1) has faced some mixed results. Prior to translating this technology to clinical care, consistent results and durable effects need to be found. We, therefore, aimed to assess the direct and long-term effects of tDCS on pain following SCI. We performed a two-phase randomized sham-controlled clinical trial where patients received 5days of tDCS followed by a 3-month follow-up period (Phase I); then, Phase II consisted of 10days of tDCS with an 8-week follow-up period. We assessed the level of pain with the Visual Analogue Scale (VAS). Patients' quality of life and life satisfaction were also evaluated. 33 patients were enrolled in Phase I and 9 in Phase II. We observed a treatment effect at 1-week follow-up for Phase I and at 4-week follow-up for Phase II. The overall level of pain was significantly lower for the active group, as compared to sham, in Phase II. Our exploratory study shows that tDCS does seem to be a promising tool to manage pain in patients with SCI and repeated stimulation sessions are needed to induce long-lasting effects. Based on our protocol, it appears that adding a second treatment period could induce long-lasting effects. Clinicaltrials.gov identification number: NCT01599767.
Keywords: Central sensitization; Neuromodulation; Pain; Spinal cord injury; Transcranial direct current stimulation; Visual analogue scale.
Copyright © 2017 Elsevier B.V. All rights reserved.
Source: PubMed
Kommende kliniske forsøg
-
NCT07939295Ikke rekrutterer endnuParkinsons sygdom (PD) | Advanced Primary PD
-
NCT07937410RekrutteringKronisk subduralt hæmatom | Tilbagevendende
-
NCT07940348Ikke rekrutterer endnuBrystkræft | Duktalt karcinom in situ
-
NCT07938060Ikke rekrutterer endnu
-
NCT07940426Ikke rekrutterer endnu
-
NCT07937930Rekruttering
-
NCT07905092Ikke rekrutterer endnu
-
NCT07938528Ikke rekrutterer endnuMedikamentbelagt ballon | Intravaskulær ultralyd | De Novo Large Coronary Vessel
-
NCT07938281Ikke rekrutterer endnu
-
NCT07938177RekrutteringKlinisk høj risiko for psykose
-
NCT07940283Ikke rekrutterer endnuMentalt helbred | Psykologisk stress
-
NCT07938567Ikke rekrutterer endnuGraviditetsrelateret | Hypertensive Disorder of Pregnancy (HDP)